Clinical Trials

Rectal Neoplasms

NCT06452602 2026-02-27

Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy in Patients With ESCC.

60 enrolled

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT03051464 2026-02-17

Morpheus

Phase 2/3 Recruiting

131 enrolled

Rectal Neoplasms

NCT05673772 2026-02-12

SOLAR

364 enrolled

Phase 2 Not yet recruiting

Rectal Neoplasms

NCT07385664 2026-02-04

FAIR

66 enrolled

Phase 2 Enrolling by invitation

Resectable Esophageal Cancer

NCT07386704 2026-02-04

Nimotuzumab Combined With Chemoradiotherapy in the Treatment of Unresectable Locally Advanced or Oligometastatic Pancreatic Cancer

30 enrolled

Pancreatic Cancer Non-resectable

NCT07346248 2026-01-16

POCAT

Enrolling by invitation

266 enrolled

Adult Patients With Locally Advanced Rectal Cancer Indicated to Neoadjuvant Therapy and Surgery

NCT03875781 2026-01-15

NORAD01

Phase 3 Recruiting

540 enrolled

Rectal Neoplasms

NCT03322995 2026-01-08

PANC

125 enrolled

Pancreatic Neoplasms

NCT03013010 2025-12-08

PREACT

Phase 3 Completed

204 enrolled

Adenocarcinoma, Stomach Neoplasms

NCT05358704 2025-12-04

Preoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal Cancer

Phase 2 Suspended

38 enrolled

Rectal Neoplasms

NCT05417386 2025-11-18

FOLFIRINOX + NIS793 in Pancreatic Cancer

Phase 1 Terminated

4 enrolled

Pancreatic Neoplasms

NCT03110926 2025-09-12

Induction Chemotherapy for Locally Advanced Esophageal Cancer

40 enrolled

Esophageal Neoplasms

NCT06048913 2025-07-04

Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age

56 enrolled

Esophageal Neoplasms

NCT07026422 2025-06-18

Iparomlimab/Tuvonralimab Integrating With Total Neoadjuvant Therapy for pMMR/MSS Locally Advanced Rectal Cancer (IT-TNT)

GastrointestinalOther neoplasm

54 enrolled

Rectal Malignant Neoplasms

NCT06997913 2025-05-31

AICRC

Enrolling by invitation

10 enrolled

Lymphatic Metastasis, Cholangiocarcinoma

NCT04821765 2025-05-30

Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer

35 enrolled

Phase 2/3 Not yet recruiting

Esophageal Neoplasms

NCT06861777 2025-03-11

Total Neoadjuvant Therapy Combined With Adebrelimab in Locally Advanced Resectable ESCC

474 enrolled

Esophageal Squamous Cell Carcinoma

NCT02972372 2025-02-10

CELAEC

Phase NA Recruiting

196 enrolled

Esophageal Neoplasms

NCT05944809 2025-01-24

The Effect of Prophylactic TPO Combined with BMS-IMRT to Esophageal Cancer Patients

Classical hematologyGastrointestinal

32 enrolled

Esophageal Neoplasms, Thrombocytopenia

NCT06758830 2025-01-09

Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.

Phase 2/3 Recruiting

400 enrolled

Low Anterior Resection Syndrome, Fatigue, Postoperative Complications, Radiation Injuries, Rectal Neoplasms

NCT05546411 2024-12-17

A Trial of NIS793 With FOLFIRINOX in Pancreatic Cancer

Phase 2 Terminated

8 enrolled 11 charts

Phase 3 Active not recruiting

Pancreatic Neoplasms

NCT03879109 2024-08-14

GRECCAR15

58 enrolled

Rectal Neoplasms

NCT03490292 2024-07-26

Avelumab With Chemoradiation for Stage II/III Resectable Esophageal and Gastroesophageal Cancer

Phase 1/2 Completed

22 enrolled 17 charts

Resectable Esophageal Cancer

NCT06429839 2024-05-28

Nimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer Patients

55 enrolled

Esophageal Neoplasms

NCT06410651 2024-05-13

Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinoma

53 enrolled

Esophageal Neoplasms

NCT04124601 2024-04-23

CHINOREC

80 enrolled

Rectal Neoplasms

NCT04543695 2024-03-26

A Study of Total Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer

255 enrolled

Rectal Neoplasms

NCT06300489 2024-03-08

Genotype-driven Weekly Irinotecan Liposomes in Combination With Capecitabine-based Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer

Phase 1 Recruiting

30 enrolled

Rectal Neoplasms

NCT02454790 2024-02-28

SFP OES

Recruiting

10,000 enrolled

Esophageal Neoplasms

NCT01691625 2024-02-07

Concurrent Chemoradiation With or Without DC-CIK Immunotherapy in Treating Locally Advanced Esophageal Cancer

Phase NA Completed

50 enrolled

Esophageal Neoplasms

NCT01515787 2024-02-02

PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery

Phase 2/3 Unknown

1,194 enrolled 25 charts

Rectal Neoplasms, Colorectal Neoplasms

NCT06239870 2024-02-02

ESTIMATE

35 enrolled

Rectal Neoplasms

NCT02676349 2023-09-28

Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44)

130 enrolled

Pancreatic Neoplasms

NCT05450029 2023-09-26

SILAR

51 enrolled

Phase NA Enrolling by invitation

Rectal Neoplasms

NCT06048926 2023-09-21

Carrelizumab Combined With Concurrent Radiotherapy and Chemotherapy for Unresectable Esophageal Squamous Cell Carcinoma

30 enrolled

Esophageal Squamous Cell Carcinoma

NCT02031939 2023-08-25

Randomized Controlled Study on Optimize Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer

Phase 3 Unknown

556 enrolled

Rectal Neoplasms

NCT01470417 2023-08-22

GAIN-1

10 enrolled 10 charts

Pancreatic Neoplasms

NCT04389086 2022-09-06

PelvEx II

Phase 3 Recruiting

364 enrolled

Margins of Excision, Rectal Neoplasms

NCT05528367 2022-09-06

Tirelizumab in Combination With Chemoradiation in Patients With Unresectable Gastric Cancer or Gastroesophageal Junction Adenocarcinoma

33 enrolled

Locally Advanced Gastric Cancer

NCT05374252 2022-05-16

Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma Patients

Phase 3 Unknown

102 enrolled

Anal Canal Carcinoma, Anus Neoplasms

NCT05339763 2022-04-21

Long Term Bowel Function Following Rectal Cancer Surgery

Phase NA Completed

171 enrolled

Rectal Neoplasms, Irritable Bowel Syndrome

NCT01889303 2022-02-14

Phase II Study of DC Versus 5-FU/CF as Chemotherapy and Concurrent Chemoradiotherapy for Locally Advanced Gastric Cancer

100 enrolled

Stomach Neoplasms

NCT04418895 2021-11-10

Neoadjuvant Therapy for Localized Rectal Adenocarcinoma

Phase 2 Withdrawn

Rectal Neoplasms

NCT02948348 2021-09-16

Study to Nivolumab Following Preoperative Chemoradiotherapy

Phase 1/2 Unknown

90 enrolled

Rectal Neoplasms

NCT04423965 2021-03-23

A Trial of Neoadjuvant mFOLFOXIRI Versus CRT in the EMVI Positive LARC

220 enrolled

Locally Advanced Rectal Cancer

NCT01224392 2020-12-30

RectumSIB

Phase 3 Completed

156 enrolled

Rectal Neoplasms, Colorectal Neoplasms

NCT01362127 2020-02-26

NeoRes

181 enrolled 9 charts

Adenocarcinoma Of Esophagus, Carcinoma, Squamous Cell

NCT04164797 2019-11-25

Study of Endostar Combined With TP Regimen for Esophageal Cancer

Phase 4 Unknown

402 enrolled